Electronic Health Record (EHR)-Based Intervention for gastroesophageal reflux disease (GERD) and Chronic non-steroidal anti-inflammatory drug (NSAID) Use

Study identifier:NIS-GUS-DUM-2007/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Using an electronic health record-based intervention and broad education reach strategies to improve quality of care for GERD and gastroprotection for patients on NSAIDs: a randomized controlled trial

Medical condition

GERD

Phase

Healthy volunteers

Study drug

Sex

All

Actual Enrollment

5234

Study type

Observational

Age

18 Years +

Date

Study Start Date: 01 Jan 2007

Primary Completion Date: 01 Jun 2008

Study Completion Date: 01 Jun 2008

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Apr 2015 by AstraZeneca Pharmaceuticals

Collaborators

Inclusion and exclusion criteria

No locations available

Arms	Assigned Interventions
1 GERD: Patients with established diagnoses of GERD based on ICD-9 codes	-
2 Atypical GERD: Patients without an established diagnosis of GERD with atypical symptoms that could be due to GERD (e.g., asthma)	-
3 Chronic NSAID users: Patients using chronic NSAIDs who are at increased risk of GI complications (defined as previous diagnosis of peptic ulcer disease; age 75 or older; or concomitant use of corticosteroids, anticoagulants, or aspirin)	-

Documents available

Trial Results Summaries
Available here

Contacts

Contact

AstraZeneca Clinical Study Information Center

1-877-240-9479

information.center@astrazeneca.com

Investigators

Principal Investigator

James M Gill

Delaware Valley Outcomes Research